Csenge Advisory Group Sells 353 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Csenge Advisory Group lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,492 shares of the healthcare conglomerate’s stock after selling 353 shares during the period. Csenge Advisory Group’s holdings in UnitedHealth Group were worth $4,971,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Kapitalo Investimentos Ltda bought a new stake in UnitedHealth Group in the fourth quarter worth $41,000. Finally, Copia Wealth Management purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $42,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. Raymond James Financial downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Wolfe Research reduced their target price on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 20th. Royal Bank Of Canada lowered their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an “overweight” rating in a research note on Friday, June 20th. Finally, Piper Sandler reduced their price objective on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a report on Tuesday, June 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $394.43.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kristen Gil acquired 3,700 shares of the company’s stock in a transaction on Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director directly owned 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 over the last 90 days. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Trading Down 2.0%

NYSE:UNH opened at $282.45 on Friday. The stock has a market cap of $256.22 billion, a PE ratio of 11.83, a price-to-earnings-growth ratio of 1.41 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The stock’s 50-day moving average is $304.47 and its two-hundred day moving average is $433.39.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 3.13%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.